Published 18:01 IST, February 12th 2024
GSK Pharma’s Q3 profit dips marginally to Rs 229 crore
GSK endured a decline in revenue for three consecutive quarters following the implementation of the NLEM.
Top 10 Pharmaceutical Companies in India by Market Capitalisation | Image:
Unsplash
- Listen to this article
- 2 min read
Advertisement
18:01 IST, February 12th 2024